Encaustic painting by Nancy Whitcomb
From The New England Council (newenglandcouncil.com)
BOSTON
”Eli Lilly & Company has partnered with UnitedHealth Group to develop promising new treatments for COVID-19. Researchers will study Eli Lilly’s new monoclonal antibody treatment for non-hospitalized patients who have recently contracted COVID-19. Read more here.
“Researchers at Harvard Medical School have published a study on the decline of emergency room visits in the early days of the pandemic. The investigators, working at Massachusetts General Hospital, raised raised concerns that critically ill patients were not seeking care because of fear of COVID-19 infection. Read more here.’’
